Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Lyumjev insulin cost?What drug company makes repatha?St joseph aspirin vs bayer low dose market share or sales?When will dupixent be available?Dupixent long term cost vs competitors?
See the DrugPatentWatch profile for Enzalutamide
The FDA approved enzalutamide (Xtandi) on August 31, 2012.
That date is the drug’s initial FDA approval for enzalutamide. Later approvals expanded or updated the labeled uses for different patient groups (for example, for earlier disease states).
DrugPatentWatch.com tracks regulatory and patent-related information for medicines, which can be used to cross-check approval timing and subsequent label changes. You can view enzalutamide coverage here: https://www.drugpatentwatch.com/ (search for “enzalutamide” on the site).
Other Questions About Enzalutamide :